LowproteinLIVING

Navigation

Add to Favourites
Close window

Low Protein Living

UK

Ireland

New Zealand

My Ketocal

UK

SHS Corporate

UK

International Sites

Argentina

France

Portugal

Sweden

The Netherlands

Consumer Options:

Search Within:

Order by:

Sort By:

HCP Options

Search Within:

Order by:

Sort By:

An Introduction to Tyrosinaemia.

TYROSINAEMIA

An Introduction to Tyrosinaemia

There are three types of Tyrosinaemia caused by disorders of tyrosine metabolism:

Tyrosinaemia Type l

Tyrosinaemia type I is caused by a deficiency of fumarylacetoacetate hydroxylase resulting in severe liver and kidney failure and eventually death. The aim of dietary management is to prevent the accumulation of phenylalanine, tyrosine and sometimes methionine by means of a low protein diet. The protein requirements are met by supplementing the diet with a tyrosine, phenylalanine and/or methionine free amino acid mixture. If NTBC is prescribed then a phenylalanine and tyrosine free protein substitute is normally used. A phenylalanine, tyrosine and methionine free protein substitute is used only when the patient is unresponsive to NTBC or it is unavailable. Whilst dietary management is important in Tyrosinaemia, NTBC has significantly improved management and survival in Tyrosinaemia type I.

Tyrosinaemia Type II

Tyrosinaemia type II is caused by a deficiency of tyrosine aminotransferase leading to eye lesions, skin lesions and neurological complications. The aim of dietary management is to prevent the accumulation of phenylalanine and tyrosine by means of a low protein diet. The protein requirements are met by supplementing the diet with a tyrosine and phenylalanine free amino acid mixture.

Tyrosinaemia Type lll

Tyrosinaemia type III is a very rare form of tyrosinaemia resulting in convulsions, ataxia and mental retardation. The aim of dietary management is to prevent the accumulation of phenylalanine and tyrosine by means of a low protein diet. The protein requirements are met by supplementing the diet with a tyrosine and phenylalanine free amino acid mixture. Guidance on amino acid intakes have been extrapolated from MRC guidelines on PKU management.

Tyrosinaemia Type I is more common than Type II and Type III is very rare. The incidence of type I is about 1 in 100,000 births in the Western World. 

To listen to a dietitian explain what Tyrosinaemia is click here.

How do you rate this article out of 5?:

Write a review of this information:

Current overall rating:

Recent Reviews for this information

Health Care Information Disclaimer

The content provided by lowproteinLIVING is for information purposes only and is in no way intended to be a substitute for medical consultation with your doctor, dietitian or healthcare professional. The information, opinions, and recommendations presented in these pages are not intended to replace the care of your own doctor, dietitian or healthcare professional. Before you make any changes in the management of your diet / treatment or any other persons diet /treatment you should always consult your doctor, dietitian or healthcare professional. Although we carefully review our content, lowproteinLIVING cannot guarantee or take responsibility for the medical accuracy of documents we publish, nor can shs-nutrition assume any liability for the content of any web site linked to our site. © 2008 SHS International. All rights reserved.